Howell-Jolly Body-Like Inclusions Correlated with Myelodysplastic Syndrome
|
By LabMedica International staff writers Posted on 07 Jan 2019 |

Image: Howell-Jolly body–like inclusion within neutrophil (arrow). It appears as a completely detached and densely basophilic inclusion in the cytoplasm of neutrophil. Photos were taken from different cases (Photo courtesy of University of Texas Health Science Center at Houston).
Howell-Jolly body–like inclusions have been previously associated with patients who are human immunodeficiency virus (HIV) infected, taking antiviral medications, and immunosuppressed. These inclusions appear in neutrophils and resemble Howell-Jolly bodies of normoblasts in abnormal erythropoiesis.
Compared with a Barr body, which appears as a drumstick-shaped appendage of a nuclear lobe, a Howell-Jolly body-like inclusion appears as a completely detached and densely basophilic inclusion in the cytoplasm of neutrophils. Howell-Jolly body-like inclusions are thought to represent a product of dysplastic granulopoiesis.
Scientists at the University of Texas Health Science Center at Houston (Houston, TX, USA) selected as a study group a total of 11 patients who underwent bone marrow biopsy and were newly diagnosed with myelodysplastic syndrome (MDS) that were treatment naïve, between 2010 and 2017. In addition, 20 treatment-naïve patients who underwent bone marrow biopsy but were diagnosed with no significant pathologic alteration in the institution were selected as the control group.
The peripheral blood and bone marrow aspirate smears were retrospectively studied. A minimum of 300 neutrophils and myeloid precursors from each bone marrow aspirate smear and 20 neutrophils from each peripheral blood smear were screened. Each patient's clinical information from the electronic medical record was reviewed to ensure none of them had a history of HIV or was taking immunosuppressants and/or antiviral medications.
The team reported eight of 11 cases (72%) in the study group showed detached intracytoplasmic inclusions in mature neutrophils consistent with Howell-Jolly body-like inclusions. Morphologically, these inclusions are densely basophilic and are “free-floating” within the neutrophilic cytoplasm. Among the eight inclusion-positive cases, Howell-Jolly body-like inclusions were identified in less than 5% of the neutrophil population. Furthermore, Howell-Jolly body-like inclusions were identified within less than 1% of the myeloid precursor population in one of the eight inclusion-positive cases. Of the 20 cases from the control group, no Howell-Jolly body-like inclusion was identified, which suggests that Howell-Jolly body-like inclusion is associated with MDS.
The authors concluded that Howell-Jolly body-like inclusions seem to correlate with immunosuppression and antiviral therapies with nucleoside analogs. They proposed that the formation of Howell-Jolly body-like inclusions is the consequence of dysplasia, and hence its correlation not only with the abovementioned conditions, but also with MDS. The inclusions are, however, seen in only a minority of white cells (<5%), which is probably why they were not brought to practicing pathologists' awareness in the past. The study was published in the January 2019 issue of the journal Archives of Pathology & Laboratory Medicine.
Related Links:
University of Texas Health Science Center at Houston
Compared with a Barr body, which appears as a drumstick-shaped appendage of a nuclear lobe, a Howell-Jolly body-like inclusion appears as a completely detached and densely basophilic inclusion in the cytoplasm of neutrophils. Howell-Jolly body-like inclusions are thought to represent a product of dysplastic granulopoiesis.
Scientists at the University of Texas Health Science Center at Houston (Houston, TX, USA) selected as a study group a total of 11 patients who underwent bone marrow biopsy and were newly diagnosed with myelodysplastic syndrome (MDS) that were treatment naïve, between 2010 and 2017. In addition, 20 treatment-naïve patients who underwent bone marrow biopsy but were diagnosed with no significant pathologic alteration in the institution were selected as the control group.
The peripheral blood and bone marrow aspirate smears were retrospectively studied. A minimum of 300 neutrophils and myeloid precursors from each bone marrow aspirate smear and 20 neutrophils from each peripheral blood smear were screened. Each patient's clinical information from the electronic medical record was reviewed to ensure none of them had a history of HIV or was taking immunosuppressants and/or antiviral medications.
The team reported eight of 11 cases (72%) in the study group showed detached intracytoplasmic inclusions in mature neutrophils consistent with Howell-Jolly body-like inclusions. Morphologically, these inclusions are densely basophilic and are “free-floating” within the neutrophilic cytoplasm. Among the eight inclusion-positive cases, Howell-Jolly body-like inclusions were identified in less than 5% of the neutrophil population. Furthermore, Howell-Jolly body-like inclusions were identified within less than 1% of the myeloid precursor population in one of the eight inclusion-positive cases. Of the 20 cases from the control group, no Howell-Jolly body-like inclusion was identified, which suggests that Howell-Jolly body-like inclusion is associated with MDS.
The authors concluded that Howell-Jolly body-like inclusions seem to correlate with immunosuppression and antiviral therapies with nucleoside analogs. They proposed that the formation of Howell-Jolly body-like inclusions is the consequence of dysplasia, and hence its correlation not only with the abovementioned conditions, but also with MDS. The inclusions are, however, seen in only a minority of white cells (<5%), which is probably why they were not brought to practicing pathologists' awareness in the past. The study was published in the January 2019 issue of the journal Archives of Pathology & Laboratory Medicine.
Related Links:
University of Texas Health Science Center at Houston
Latest Hematology News
- Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
- Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
- ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
- Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage
- Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
- Platelets Could Improve Early and Minimally Invasive Detection of Cancer
- Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment
- Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
- First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes

- New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
- Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
- WBC Count Could Predict Severity of COVID-19 Symptoms
- New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
- Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
- POC Hemostasis System Could Help Prevent Maternal Deaths
- New Test Assesses Oxygen Delivering Ability of Red Blood Cells by Measuring Their Shape
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read moreMolecular Diagnostics
view channel
Simple Urine Test to Revolutionize Bladder Cancer Diagnosis and Treatment
Bladder cancer is one of the most common and deadly urological cancers and is marked by a high rate of recurrence. Diagnosis and follow-up still rely heavily on invasive cystoscopy or urine cytology, which... Read more
Blood Test to Enable Earlier and Simpler Detection of Liver Fibrosis
Persistent liver damage caused by alcohol misuse or viral infections can trigger liver fibrosis, a condition in which healthy tissue is gradually replaced by collagen fibers. Even after successful treatment... Read moreImmunology
view channel
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read moreMicrobiology
view channel
Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
Sepsis kills 11 million people worldwide every year and generates massive healthcare costs. In the USA and Europe alone, sepsis accounts for USD 100 billion in annual hospitalization expenses.... Read moreRapid POC Tuberculosis Test Provides Results Within 15 Minutes
Tuberculosis remains one of the world’s deadliest infectious diseases, and reducing new cases depends on identifying individuals with latent infection before it progresses. Current diagnostic tools often... Read more
Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read morePathology
view channel
Tunable Cell-Sorting Device Holds Potential for Multiple Biomedical Applications
Isolating rare cancer cells from blood is essential for diagnosing metastasis and guiding treatment decisions, but remains technically challenging. Many existing techniques struggle to balance accuracy,... Read moreAI Tool Outperforms Doctors in Spotting Blood Cell Abnormalities
Diagnosing blood disorders depends on recognizing subtle abnormalities in cell size, shape, and structure, yet this process is slow, subjective, and requires years of expert training. Even specialists... Read moreTechnology
view channel
Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read moreIndustry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more








